Even as popular diabetes drugs like Januvia and Actos continue to come under scrutiny, another diabetes drug has recently made headlines. Concerns over Onglyza heart failure have prompted a review by an FDA panel, which could lead to a label change for this drug and others like it. As “mortality”... Read more »

Dara Goldstein, individually and as successor in interest of the estate of Samuel Goldstein, has submitted a short form complaint for monetary damages against Merck, Sharpe & Dohme. The plaintiff claims that her now deceased husband developed pancreatic cancer and subsequently died as a direct result of taking the diabetes... Read more »